Oncolytic virus driven T-cell-based combination immunotherapy platform for colorectal cancer

Colorectal cancer is the third most diagnosed cancer and the second leading cause of cancer mortality worldwide, highlighting an urgent need for new therapeutic options and combination strategies for patients. The orchestration of potent T cell responses against human cancers is necessary for effect...

Descripción completa

Detalles Bibliográficos
Autores principales: Crupi, Mathieu J. F., Taha, Zaid, Janssen, Thijs J. A., Petryk, Julia, Boulton, Stephen, Alluqmani, Nouf, Jirovec, Anna, Kassas, Omar, Khan, Sarwat T., Vallati, Sydney, Lee, Emily, Huang, Ben Zhen, Huh, Michael, Pikor, Larissa, He, Xiaohong, Marius, Ricardo, Austin, Bradley, Duong, Jessie, Pelin, Adrian, Neault, Serge, Azad, Taha, Breitbach, Caroline J., Stojdl, David F., Burgess, Michael F., McComb, Scott, Auer, Rebecca, Diallo, Jean-Simon, Ilkow, Carolina S., Bell, John Cameron
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9670134/
https://www.ncbi.nlm.nih.gov/pubmed/36405739
http://dx.doi.org/10.3389/fimmu.2022.1029269

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9670134/
https://www.ncbi.nlm.nih.gov/pubmed/36405739
http://dx.doi.org/10.3389/fimmu.2022.1029269

Ejemplares similares